High-resolution images
FSHARP
August 2025
The Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program will develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings.
At the end of the program, deliverables will be formulations that recapitulate the most critical functions of whole blood without requirement for cold chain, and are tailorable to different injury profiles requiring specific therapeutic adaptations (e.g., hemorrhage with trauma induced coagulopathy, traumatic brain injury, or other concurrent injury).
